Evidence map›Paper›PMID 42559159›Full record

ArticleJournal of applied crystallography2026

NeuDiff Agent: a governed AI workflow for single-crystal neutron crystallography.

Zhongcan Xiao, Leyi Zhang, Guannan Zhang, Xiaoping Wang

Abstract read
In one paragraph

Article in Journal of applied crystallography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhongcan XiaoNeutron Scattering Division Oak Ridge National Laboratory Oak Ridge TN37831 USA.
Leyi ZhangNeutron Scattering Division Oak Ridge National Laboratory Oak Ridge TN37831 USA.
Guannan ZhangComputer Science and Mathematics Division Oak Ridge National Laboratory Oak Ridge TN37831 USA.
Xiaoping WangNeutron Scattering Division Oak Ridge National Laboratory Oak Ridge TN37831 USA.ORCID https://orcid.org/0000-0001-7143-8112

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large-scale facilities increasingly face analysis and reporting latency as a limiting step in scientific throughput, particularly for structural studies that require iterative reduction, integration, refinement and validation. To improve the time to result and analysis efficiency, NeuDiff Agent is introduced as a governed, tool-using AI workflow for TOPAZ at the Spallation Neutron Source. NeuDiff Agent takes instrument data through reduction, integration, refinement and validation to a validated crystal structure and a publication-ready CIF. NeuDiff Agent coordinates established crystallographic tools under explicit governance by restricting actions to allowlisted tools, enforcing fail-closed verification gates at key workflow boundaries, and capturing complete provenance for inspection, auditing and controlled replay. The present benchmark is limited to structural crystallography for periodic structures; magnetic structure analysis and incommensurate or superspace refinement are outside the scope of the current workflow. Performance is assessed using a fixed prompt protocol and repeated end-to-end runs with two large language model backends, with user and machine time partitioned and intervention burden and recovery behaviors quantified under gating. In a reference-case benchmark, NeuDiff Agent reduces wall time from 435 min (manual) to 86.5 ± 4.7 to 94.4 ± 3.5 min (4.6-5.0× faster) while producing a validated CIF with no

Indexed as

checkCIF validationcrystallographic validationcrystallographic workflow automationgoverned AI workflowslarge language modelssingle-crystal neutron diffraction

Identifiers

PMID42559159
PMCPMC13440046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.